adipose tissue metabolism; liver; leucine metabolism; cholesterol synthesis THERE IS considerable evidence suggesting that the metabolic degradation of leucine occurs primarily at peripheral sites (16, 20, 23, 30) . Indeed, transamination of leucine and other branched-chain amino acids is mainly a function of the extrahepatic tissues (20) . Leucine is metabolized through several intermediary steps to P-hydroxy-P-methylglutarylCoA (HMG-CoA), a direct precursor of cholesterol (24). Since HMG-CoA can be further converted to acetoacetate and acetyl-CoA, it is clear that leucine can serve as a potential precursor of several major classes of lipids including cholesterol (24) . Recently, Miettinen and Penttila (27) have demonstrated that in the human leucine may be an important precursor of serum cholesterol and that muscle may be the major extrahepatic source of cholesterol newly synthesized from leucine (26) .
Numerous investigations have shown that adipose tissue and isolated fat cells from rats and mice can convert Lleucine into protein, fatty acid, and carbon dioxide (7, 14, 18, 23, 33) . This report examines the quantitative significance of leucine incorporation into protein, carbon dioxide, fatty acid, and sterols in rat adipose tissue and cells by comparing it with that of muscle and liver. The results
show that adipose tissue plays a major role in peripheral utilization of leucine, and that sterol synthesis from leucine in adipose tissue is a quantitatively significant reaction which is stimulated by the addition of glucose and insulin.
MATERIALS AIKD METHODS
Preparation of tissue and cells. Male Wistar rats (ca. 200 g) were fed Purina chow ad libitum.
The animals were killed by stunning and cervical dislocation.
Isolated white adipose cells were obtained by a modification of the procedure of Rodbell (3 1). Epididymal fat was digested for 1 h in KrebsRinger-bicarbonate (KRB) medium containing 1.27 mM Ca++, 5 % bovine serum albumin (fraction V, Armour Pharmaceutical Company, Chicago), 1.6 mg/ml collagenase (Clostridium histoly ticum, Worthington Biochemical Corp., Freehold, N-J.), and 3 mM glucose. The free cells were washed 3 times in 5 % KRB-albumin and dispensed into Nalgene flasks for incubation in a Dubnoff metabolic shaker at 37°C with 95 % 02--5 % CO2 as the gas phase. After incubation the cells were separated from the medium as previously described (3).
Human adipose tissue was obtained from three subjects undergoing elective orthopedic surgery. They had no known metabolic disorders and had fasted for 12-16 h prior to surgery. The tissue was placed in saline (.9 % NaCl) until transferred to the appropriate incubation medium. Free cells were prepared by the same procedure used for rat epididymal fat (31), with doubling of the collagenase concentration during digestion. The free cells and pieces of human adipose tissue were otherwise treated in the same way as rat cells and tissue.
In experiments in which rat epididymal fat-pads, liver slices, quadriceps femoris, or diaphragm were to be obtained, the rats were maintained under light ether anesthesia during tissue removal. The tissues were incubated for 4 h in 2 ml Krebs-Ringer-bicarbonate buffer containing 5 % bovine serum albumin pH 7.4 at 37°C in a shaking water bath with 95 % 02-5 % CO2 as the gas phase.
In the experiments in which carbon dioxide was collected the flasks were gassed with 95 % 02-5 % CO2 and capped. Carbon dioxide was collected on fluted fiilter papers in disposable plastic center wells (Kontes Glass Company, Vineland, N-J.) attached to the rubber caps. At the end of the incubation period, 0.2 ml of 0.1 N HzS04 was added to the medium and 0.2 ml Hyamine 10X (Packard Instrument Co.) was added to the filter paper. After incubating for an additional 20 min, the filter papers were removed for counting.
Extructjon of total l$ids. Isolated fat-cell lipids were directly extracted with chloroform-methanol (2: 1 v/v) by mixing on a vortex agitator.
Pieces of tissue were rinsed in KRB medium prior to homogenization and extraction. Using a Potter-Elvehjem-type tissue grinder, adipose tissue was homogenized in 5 ml of chloroform-methanol and liver and muscle, in .5 ml saline. Chloroform-methanol was added to the homogenized tissue or cells to a final volume of 10 or 20 ml and the mixture was kept for 1 h at room temperature.
The extracts were filtered through no. 1 Whatman paper, and the paper was rinsed twice with fresh chloroformmethanol. The filter paper was allowed to air-dry, then cut into shreds and stored in glass vials for protein determinations.
Total lipid extracts of cells and tissues were prepared by the method of Folch et al. (15) water, the NSL were extracted with petroleum ether, evaporated, and resaponified for 1 h at 60°C in 5 ml of absolute ethanol plus .3 ml of 33 % KOH (w/v). Following the second saponification the NSL were reextracted and washed twice in a solution of .Ol N NaOH in 44 % ethanol. Aliquots of the NSL were then taken for counting. Recovery of 14C-labeled NSL lipids from total lipids through the two saponifications and washings averaged 84 %. Less than 10 % of the activity in the NSL fraction represented contamination by free fatty acids while another 10 % represented contamination by lower glycerides. To determine total fatty acid content 1 drop of 1 % phenolphthalein (in 95 % ethanol) was added to the alcoholic-KOH phase remaining after the first saponification. To this, 8 N HCl was added drop by drop until the solution was neutralized and the pink color cleared. The samples were then heated for 10 min in a 55°C water bath and cooled to room temperature.
The fatty acids were extracted in petroleum
ether. An aliquot of the petroleum ether extract was evaporated and washed according to the method of Folch et al. (15) . A portion of the washed extract was weighed to determine total fatty acid content and then counted.
Thin-layer chromatography. As illustrated in Fig. 1 , rat epididymal fat readily converted leucine -14C into lipids, primarily the fatty acid fraction. The rate of synthesis of nonsaponifiable lipids was 1.5 % that of fatty acid with 0.1 mM leucine and . To determine the extent of interaction between leucine and glucose substrates, the effect of unlabeled leucine on glucose-14C and unlabeled glucose on leucine-14C conversion to fatty acid and NSL was examined in isolated adipocytes ( Table 2) . As observed in whole adipose tissue (Table 1) , the addition of glucose markedly enhanced leucine-14C incorporation into newly synthesized lipids in free adipocytes. Leucine (0.1 mM), on the other hand, had no effect on the rate of glucose-1JC conversion to lioids. amino acids (Table  3) . Leucine incorporation into newly synthesized NSL and sterols was 10 times greater than for isoleucine, while valine was poorly utilized when compared to either leucine or isoleucine (Table 3) . When the results in Fig. 1 and Table 3 were compared, it appeared that the rate of leucine utilization for lipid syn-thesis differed in whole adipose tissue compared to isolated cells. By combining the results of five experiments, total lipid synthesis from leucine was found to be approximately 10 times higher in free cells than in whole adipose tissue (Table 4 ). This may be related to differences in permeability of cells and tissue to substrate and to the rate of release of products into the medium. Approximately 85 % of the total lipids were in the fatty acid fraction for both free cells and whole tissue. There was a pronounced difference in the distribution of leucine carbons in the NSL fractions of whole tissue and free cells. In whole tissue 55 % of the newly synthesized NSL was in the total sterol fraction and 22 % was in hydrocarbons and squalene. One-half of the total sterol activity was cholesterol.
In contrast, in isolated fat cells only 20 % of the newly synthesized ML were in the total sterol fraction and 38 % in hydrocarbons plus squalene. Less than one-fifth of the sterol activity was cholesterol.
The rate of cholesterol synthesis from leucine in intact tissue was sevenfold greater than that seen in isolated cells.
In the rat, the liver has been considered the major site of cholesterol synthesis (8). Since acetate is frequently used in studies of cholesterol synthesis, its rate of utilization in liver was compared to that of leucine (Table 5 ). As expected, rat liver slices were found to incorporate acetate into fatty acid, NSL, and sterols at rates many times greater (approximately 20-fold on a substrate-carbon basis) than that for leucine (Table 5 ). In spite of this difference in the rate of cholesterol (n = 6 acetate, n = 5 leucine). Rat liver slices (ca. 200 mg) were incubated i n the presence of 10 mM glucose plus 1.0 mM L-l euci ne-UL-14C (1.2 X l o7 counts/min) or 1.0 mM acetate-l -14C (5.8 X l o6 counts/ min).
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synthesis, more than 80 % of the newly synthesized NSL was cholesterol with either substrate. The significance of the difference in substrate preference by liver became apparent in the study described in Tables 6 and 7, in which rates of  leucine metabolism in adipose tissue, muscle, and liver were compared.
The experiment described in Tables 6 and 7 was undertaken to determine the quantitative significance of adipose tissue, muscle, and liver with respect to leucine disposal. These tissues were chosen for study because they represent major sites of fatty acid and cholesterol synthesis and/or storage (8, 10) and major sites of leucine oxidation (16, 23, 30) . The incorporation of leucine into carbon dioxide (CO,), protein, and lipid was significantly greater in adipose tissue (expressed per gram wet weight or per milligram protein) than in either liver or muscle (Table 6 ). In adipose tissue, insulin (1 mu/ml) increased leucine conversion to lipid fourfold but had no effect on 14C02 or 14C-labeled protein production.
Insulin had little effect on leucine utilization in liver or muscle, with the exception that in liver slices, leucine incorporation into protein was significantly increased (P < .05) by insulin when expressed on a milligrams-ofprotein basis. Only in adipose tissue was a large fraction (40 70) of the leucine carbons converted to lipid. In liver 90 % of the leucine was incorporated into protein, while in muscle conversion to CO, and protein was the major metabolic fate of leucine (Table 6 ). Nonsaponifiable lipid synthesis from leucine occurred in all three tissues (Table 7) . Based on tissue wet weight, the rates of synthesis of NSL and total sterols in adipose tissue and liver were similar. However, a larger proportion of the activity in liver sterols was in cholesterol (98 %) compared to adipose tissue (32 %)-I n muscle the incorporation of leucine into the NSL fractions occurred at approximately 10 % the rate observed in adipose tissue (Table 7) .
The addition of insulin (1 mu/ml) doubled NSL synthesis in adipose tissue but had no effect in liver or muscle (Table 7) . The major effect of insulin was a fivefold increase in squalene and whereas cholesterol synthesis was not quite doubled.
hydrocarbon synthesis from leucine,
The expression of the data in Tables 6 and 7 in terms of tissue protein emphasizes the high capability of the active cellular mass of adipose tissue to utilize leucine when compared to muscle or liver. In addition, the estimates for w .holeorgan activity show th .at adipose tissue, like muscle, is a major extrahepatic site of leucine disposal. The importance of both adipose tissue and muscle as peripheral sites of leucine metabolism prompted further comparison of these two tissues. In the experiment described in Table 8, utilization of leucine-14C and glucose-J4C by adipose tissue and hemidiaphragms is compared. In this experiment the synthetic activity of hemidiaphragms, with leucine as substrate, was approximately 2 times greater than that of the quadriceps femoris described in Table 6 . This may be attributed to the difference in muscle thickness, the cutting of the diaphragm, and, therefore, the ability of leucine to enter these two muscle types.
In adipose tissue, glucose-W was more readily incorporated into carbon dioxide and fatty acid than was leucine-14C ( On comparing adipose tissue to hemidiaphragm (based on activity per gram wet weight) it was observed that the rate of conversion of each substrate to 14C02 was similar, that incorporation into protein of either leucine or glucose occurred at significantly higher rates (P < .02) in diaphragm than in adipose tissue, and that the rate of incorporation of either substrate into fatty acid, NSL, and hydrocarbons and squalene was significantly higher (P < .OS) in adipose tissue than diaphragm (Table 8) . It is also apparent that total sterol synthesis from leucine was 4 times greater in adipose tissue than in muscle (P < .OOl), whereas glucose incorporation into total sterols was the same in both tissues (Table 8) . The difference in leucine-14C incorporation into cholesterol in adipose tissue was not significantly (P < .l) greater than in hemidiaphragm because of the large variation.
or ML. However, for the synthesis of sterols and hydrocarbons and squalene in adipose tissue, leucine was incorporated at rates twice that of glucose. The data further suggest that in adipose tissue leucine is more readily incorporated into cholesterol than is glucose (Table 8 ). In hemidiaphragm, the preferential utilization of glucose over lcucine for carbon dioxide and fatty acid production was also observed (Table  8) . Both 14C-labeled substrates were incorporated into protein at similar rates. Glucose-W was more readily incorporated into NSL than was leucineJ4C.
However, no difference was observed between the two substrates for the synthesis of total sterols or hydrocarbons and squalene. The results also suggest that in hemidiaphragm glucose-1% is more readily incorporated into cholesterol than is leucine-14C (Table 8) . approximately-1.5 % of the newly synthesized lipids. The rate of leucine conversion to lipids and NSL in human tissue was 1-2 % that observed in rat adipose tissue (Fig. 1) .
DISCUSSION
Entry of leucine and isoleucine carbons into lipids would be expected from their degradative intermediates which serve as lipid precursors.
Oxidative metabolism of leucine generates HMG-CoA as well as acetoacetate and acetylCoA, while isoleucine produces acetyl-CoA (24). Thus, it is not surprising that free adipocytes like whole tissue are able to utilize leucine and isoleucine for fatty acid (Table 2) and sterol (Tables 3 and 4) synthesis. Although valine is oxidized in adipose tissue (13), it generates none of these lipid precursors, thereby accounting for the low rate of valine carbon incorporation into lipids in free adipocytes (Table  3 ). The present report demonstrates that the adipose organ is a major e,xtrahepatic site of leucine disposal in the rat and, in particular, that adipose tissue is a quantitatively important site of fatty acid and sterol synthesis from leucine.
The results of the present study indicate that the rate of leucine uptake and metabolism in fat tissue is sensitive to substrate (leucine and glucose) concentration as well as to insulin.
Furthermore, these changes in rate of leucine metabolism occur at substrate concentrations found in the intact animal. In the rat the plasma leucine concentration varies from .19 mM in the fed animal to .75 mM in the fasted animal (23). As shown in Fig. 1 , the rate of synthesis of NSL and sterols in adipose tissue increased IO-fold by an increase in leucine concentration from 0.10 to 1 .O mM and was further enhanced by physiological concentrations of glucose (Tables 1 and 2 ). This suggests that the observations made in vitro may reflect physiological events in vivo. and a-glutarate) for leucine deamination. It is not oossible to choose from available data whether one or more of these possible explanations apply. It is significant that isotope dilution did not occur in the experiments comparing the effect of glucose on leucine conversion to sterols, and the effect of leucine on glucose conversion to sterols (Table 2 ). This would suggest that the rates of leucine and glucose conversion to sterols are additive and that, at physiological concentrations of these substrates, the rate of sterol synthesis in fat tissue is well below V,,,, .
The stimulatory effects of insulin on leucine utilization differed in each tissue. In muscle, insulin had no significant effect on leucine conversion to CO, , total lipid, or protein, while in liver slices insulin did cause a small (25 "r) but significant increase in protein synthesis (Table  6 ). The greatest effect occurred in adipose tissue where insulin increased leucine conversion to total lipid fourfold (Table 6 ). However, insulin did not significantly alter net conversion of leucine to CO, or incorporation into protein in adipose tissue (Table 6 ). This is in general agreement with previous findings (7, 18, 23) , but differs in certain respects with others (18, Zi, 33) who h ave noted an actual decrease in leucine conversion to CO, following insulin addition. This presumably is due to isotope dilution following increased entry of unlabeled glucose (7, 33). The failure of insulin to stimulate leucine conversion to protein in fat tissue also differs from previous findings (7, 19) . 0 ne explanation of our findings is that the substrate concentration (1 .O mM) in the experiment described in Table 6 stimulated transport of leucine close to V 1113s ) hence no further stimulation by insulin would be observed (17). The importance of adipose tissue as an extrahepatic site of leucine metabolism is demonstrated by comparison with liver and muscle on a whole-organ basis (Tables 6 and 7) . Th e results of this experiment show that the adipose organ utilizes 3 times as much leucine as liver and half as much leucine as muscle for the combined production of carbon dioxide, protein, and lipids. Furthermore, on the addition of insulin, leucine disposal in the adipose organ is increased to a much greater extent than in liver and muscle. The whole-organ data in Table 8 presents further evidence that adipose tissue as well as muscle is a significant peripheral site of leucine disposal. It is important to appreciate that whole-organ estimates were based on a number of assumptions:
first, that the total adipose mass in a rat equals 7 % of body weight and that muscle equals 45.5 o/o of body weight (6). (Total liver weight was measured directly and represents 4.15 % of total body weight.) Accordingly, in a 200-g rat, there would be 14 g fat, 91 g muscle, and 8.3 g of liver. Second, it was assumed that the rates of leucine utilization in epididymal fat and quadriceps femoris or diaphragm were representative of all adipose tissue and muscle in the body. These assumptions are subject to the following reservations: a) adipose tissue may actually comprise more than 7 % of the body weight of a normal rat, since this value was obtained by direct dissection only (6, 10); 6) the metabolic activity of adipose tissue varies with anatomic location (32); c) the rate of leucine utilization does vary with the particular muscle examined (30). Nevertheless, the estimates of whole-organ activity are consistent with the view that both adipose tissue and muscle are important peripheral sites of leucine disposal and that conversion of leucine to sterols, particularly cholesterol, should be regarded as a significant physiological function of adipose tissue.
Recently Farkas et al. (10) demonstrated that rat adipose tissue is a major cholesterol storage organ, accumulating increasing amounts of cholesterol as the age and size of the rat increased.
They have reported that 65-90% of this cholesterol is located in the adipocyte and the remainder in the stromal and vascular elements of the tissue. The results of several studies using mevalonate and acetate as precursors have clearly shown that adipose tissue is more than a passive cholesterol storage site and is capable of sterol synthesis (8, 9). Of more physiological importance, it has now been demonstrated here that adipose tissue and free fat cells are able to synthesize sterols and cholesterol from physiological precursors, leucine and glucose. To what extent this contributes to total-body cholesterol production or serum cholesterol levels is an important consideration and is worth some discussion.
The role of leucine as a precursor of body cholesterol in the rat was first demonstrated by Bloch in 1944 (4). More recently, incorporation of leucine-3H into serum cholesterol in both rats and humans has been reported (26, 27). Miettinen and Penttila (26, 27) have suggested that muscle may be the major extrahepatic site where leucine is converted into cholesterol prior to release into the circulation. However, the data reported here (Table 5) indicate that the adipose organ may be just as active a site of sterol synthesis as muscle. Obesity in humans is associated with an increased rate of cholesterol production (29) which can be decreased by weight reduction (25) . Since the proportion of body weight represented by fat tissue in obesity may greatly exceed the normal 15 % (21, 28), the adipose organ must be viewed as a potential source of this cholesterol. The role of leucine as a precursor must now be considered in light of the preliminary data in Table  9 , which suggest that human adipose tissue can utilize leucine for sterol synthesis and the fact that plasma leucine and insulin levels are elevated in obese man (11). Whether leucine conversion to sterols contributes significantly to the increased cholesterol production rate observed in obese man awaits further experimentation.
